Probiotics, prebiotics and colorectal cancer prevention

Best Practice and Research: Clinical Gastroenterology

Volumn 30, Issue 1, 2016, Pages 119-131

  Ambalam, Padma ^a   Raman, Maya ^b   Purama, Ravi Kiran ^c   Doble, Mukesh ^b  

^a Christ College   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^c NATIONAL INSTITUTE OF TECHNOLOGY CALICUT   (India)

Author keywords

Bifidobacteria; Colorectal cancer; Gut microbiota; Lactobacillus; Prebiotics; Probiotics; Synbiotics

Indexed keywords

ANTIMUTAGENIC AGENT; ANTINEOPLASTIC AGENT; CARCINOGEN; PREBIOTIC AGENT; PROBIOTIC AGENT; PROTEIN TYROSINE KINASE; SYNBIOTIC AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL DIFFERENTIATION; COLON CARCINOGENESIS; COLORECTAL CANCER; DYSBIOSIS; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; INTESTINE FLORA; NONHUMAN; SIGNAL TRANSDUCTION; STOMACH PH; COLORECTAL NEOPLASMS; DIET; IMMUNE SYSTEM; MICROBIOLOGY; PHYSIOLOGY;

ANTICARCINOGENIC AGENTS; COLORECTAL NEOPLASMS; DIET; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE SYSTEM; PREBIOTICS; PROBIOTICS;

EID: 84959460952     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2016.02.009     Document Type: Review

References (121)

1. M. DeBarros, and S.R. Steele Colorectal cancer screening in an equal access healthcare system J Cancer 4 2013 270
2. D. Commane, R. Hughes, C. Shortt, and I. Rowland The potential mechanisms involved in the anti-carcinogenic action of probiotics Muta Res 591 2005 276 289
3. A. Biondi, R. Fisichella, F. Fiorica, M. Malaguarnera, and F. Basile Food mutagen and gastrointestinal cancer Eur Rev Med Pharmacol Sci 16 2012 1280 1282
4. B.W. Stewart, and P. Kleihues World cancer report 2003 IARC press Lyon 57
5. M. Jägerstad, and K. Skog Genotoxicity of heat-processed foods Muta Res 574 2005 156 172
6. A.J. Cross, L.M. Ferrucci, A. Risch, B.I. Graubard, M.H. Ward, Y. Park, and et al. Large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association Cancer Res 70 2010 2406 2414
7. Q. Feng, S. Liang, H. Jia, A. Stadlmayr, L. Tang, Z. Lan, and et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence Nat Commun 6 2015 6528
8. L.I. Vorobjeva, and S.K. Abilev Antimutagenic properties of bacteria: review Appl Biochem Microbiol 38 2002 97 107
9. M. Raman, U. Nilsson, K. Skog, M. Lawther, B. Nair, and M. Nyman Physicochemical characterization of dietary fibre components and their ability to bind some process-induced mutagenic heterocyclic amines, Trp-P-1, Trp-P-2, AαC and MeAαC Food Chem 138 2013 2219 2224
10. M. Raman, and M. Doble Physicochemical characterization of wheat bran and Kappaphycusalvarezii dietary fibres and their ability to bind mutagens, PhIP, Trp-P-2, AαC and BαP LWT-Food Sci Tech 63 2015 169 176
11. M. Raman, and M. Doble κ-Carrageenan from marine red algae, Kappaphycusalvarezii-A functional food to prevent colon carcinogenesis J Funct Foods 15 2015 354 364
12. T. Norat, C. Scoccianti, M.C. Boutron-Ruault, A. Anderson, F. Berrino, M. Cecchini, and et al. European code against cancer 4th edition: diet and cancer Cancer Epidemiol 39 2015 S56 S66
13. V.P. Gourineni, M. Verghese, J. Boateng, L. Shackelford, N.K. Bhat, and L.T. Walker Combinational effects of prebiotics and soybean against azoxymethane-induced colon cancer in vivo J Nutr Metab 2011 2011 868197
14. N. Sutandyo Nutritional carcinogenesis Acta Med Indones 42 2010 36 42
15. F. Sommer, and F. Bäckhed The gut microbiota-masters of host development and physiology Nat Rev Microbiol 11 2013 227 238
16. I. Sekirov, S.L. Russell, L.C. Antunes, and B. Finlay Gut microbiota in health and disease Physiol Rev 90 2010 859 904
17. K. Aagaard, J. Ma, K.M. Antony, R. Ganu, J. Petrosino, and J. Versalovic The placenta harbors a unique microbiome Sci Transl Med 6 2014 237ra65
18. S. Bermon, B. Petriz, A. Kajėnienė, J. Prestes, and L. Castell The microbiota: an exercise immunology perspective Exerc Immunol Rev 21 2015 70 79
19. Y.W. Min, and P.L. Rhee The Role of microbiota on the gut immunology Clin Ther 37 2015 968 975
20. I. Sobhani, A. Amiot, Y. Le Baleur, M. Levy, M.L. Auriault, J.T. Van Nhieu, and et al. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Ther Adv Gastroenterol 6 2013 215 229
21. C. Dejea, E. Wick, and C.L. Sears Bacterial oncogenesis in the colon Future Microbiol 8 2013 445 460
22. C. Kasai, K. Sugimoto, I. Moritani, J. Tanaka, Y. Oya, H. Inoue, and et al. Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: terminal restriction fragment length polymorphism and next-generation sequencing analyses Oncol Rep 35 2016 325 333
23. T. Sasada, T. Hinoi, Y. Saito, T. Adachi, Y. Takakura, Y. Kawaguchi, and et al. Chlorinated water modulates the development of colorectal tumours with chromosomal instability and gut microbiota in Apc-deficient mice PLos One 10 2015 e0132435
24. A.C. Ericsson, S. Akter, M.M. Hanson, S.B. Busi, T.W. Parker, R.J. Schehr, and et al. Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota Oncotarget 6 2015 33689 33704
25. A. Bashir, A.Y. Miskeen, A. Bhat, K.M. Fazili, and B.A. Ganai Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis Eur J Cancer Prev 24 2015 373 385
26. M. Castellarin, R.L. Warren, J.D. Freeman, L. Dreolini, M. Krzywinski, J. Strauss, and et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma Genome Res 22 2012 299 306
27. A.D. Kostic, E. Chun, L. Robertson, J.N. Glickman, C.A. Gallini, M. Michaud, and et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumour-immune microenvironment Cell Host Microbe 14 2013 207 215
28. M.R. Rubinstein, X. Wang, W. Liu, Y. Hao, G. Cai, and Y.W. Han Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signalling via its FadAadhesin Cell Host Microbe 14 2013 195 206
29. K. Mima, Y. Sukawa, R. Nishihara, Z.R. Qian, M. Yamauchi, K. Inamura, and et al. Fusobacterium nucleatum and T cells in colorectal carcinoma JAMA Oncol 1 2015 653 661
30. Y.W. Han Fusobacterium nucleatum: a commensal-turned pathogen Curr Opin Microbiol 23 2015 141 147
31. C.L. Sears, A.L. Geis, and F. Housseau Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis J Clin Invest 124 2014 4166 4172
32. A. Boleij, E.M. Hechenbleikner, A.C. Goodwin, R. Badani, E.M. Stein, M.G. Lazarev, and et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients Clin Infect Dis 60 2015 208 215
33. H.M. Martin, B.J. Campbell, C.A. Hart, C. Mpofu, M. Nayar, R. Singh, and et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer Gastroenterology 127 2004 80 93
34. G. Cuevas-Ramos, C.R. Petit, I. Marcq, M. Boury, E. Oswald, and J.P. Nougayrède Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells Proc Natl Acad Sci U. S. A 107 2010 11537 11542
35. J.C. Arthur, E. Perez-Chanona, M. Mühlbauer, S. Tomkovich, J.M. Uronis, T.J. Fan, and et al. Intestinal inflammation targets cancer-inducing activity of the microbiota Science 338 2012 120 123
36. J. Corredoira-Sánchez, F. García-Garrote, R. Rabuñal, L. López-Roses, M.J. García-País, E. Castro, and et al. Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case-control study Clin Infect Dis 55 2012 491 496
37. A. Boleij, B.E. Dutilh, G.A. Kortman, R. Roelofs, C.M. Laarakkers, U.F. Engelke, and et al. Bacterial responses to a simulated colon tumor microenvironment Mol Cell Proteomics 11 2012 851 862
38. M. Martins, L. Aymeric, L. du Merle, C. Danne, C. Robbe-Masselot, P. Trieu-Cuot, and et al. Streptococcus gallolyticus Pil3 Pilus is required for adhesion to colonic mucus and for colonization of mouse distal colon J Infect Dis 212 2015 1646 1655
39. Y. Yang, X. Wang, T. Huycke, D.R. Moore, S.A. Lightfoot, and M.M. Huycke Colon macrophages polarized by commensal bacteria cause colitis and cancer through the bystander effect Transl Oncol 6 2013 596 606
40. X. Wang, T.D. Allen, Y. Yang, D.R. Moore, and M.M. Huycke Cyclooxygenase-2 generates the endogenous mutagen trans-4-hydroxy-2-nonenal in Enterococcus faecalis-infected macrophages Cancer Prev Res (Phila) 6 2013 206 216
41. G. Reid Probiotics: definition, scope and mechanisms of action Best Pract Res Clin Gastroenterol 30 1 2016 17 25
42. C. Hill, F. Guarner, G. Reid, G.R. Gibson, D.J. Merenstein, B. Pot, and et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic Nat Rev Gastroenterol Hepatol 11 2014 506 514
43. M. Raman, P. Ambalam, K.K. Kondepudi, S. Pithva, C. Kothari, A.T. Patel, and et al. Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer Gut Microbes 4 2013 181 192
44. V. Liévin-Le Moal, and A.L. Servin Anti-infective activities of Lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents Clin Microbiol Rev 27 2014 167 199
45. P. Ambalam, J.M. Dave, B.M. Nair, and B.R. Vyas In vitro mutagen binding and antimutagenicacitivity of human Lactobacillus rhamnosus 231 Anaerobe 17 2011 217 222
46. S.P. Pithva, P.S. Ambalam, J.M. Ramoliya, J.M. Dave, and B.R. Vyas Antigenotoxic and antimutagenic activities of probiotic Lactobacillus rhamnosus Vc against N-Methyl-N'-Nitro-N-Nitrosoguanidine Nutr Cancer 67 2015 1142 1150
47. C.L. Sears, and W.S. Garrett Microbes, microbiota, and colon cancer Cell Host Microbe 15 2014 317 328
48. G.A. Plotnikoff Three measurable and modifiable enteric microbial biotransformations relevant to cancer prevention and treatment Glob Adv Health Med 3 2014 33 43
49. A.M. Stringer, R.J. Gibson, R.M. Logan, J.M. Bowen, A.S. Yeoh, and D.M. Keefe Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhoea model in rats Cancer Biol Ther 7 2008 1919 1925
50. P. Louis, G.L. Hold, and H.J. Flint The gut microbiota, bacterial metabolites and colorectal cancer Nat Rev Microbiol 12 2014 661 672
51. M.J. Ostaff, E.F. Stange, and J. Wehkamp Antimicrobial peptides and gut microbiota in homeostasis and pathology EMBO Mol Med 5 2013 1465 1483
52. B. Pool-Zobel, S. Veeriah, and F.D. Böhmer Modulation of xenobiotic metabolising enzymes by anticarcinogens-focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis Mutat Res 591 2005 74 92
53. G.J. Hammons, and B.D. Lyn-Cook Modulation of biotransformation enzymes in cancer chemoprevention Int J Cancer Prev 1 2004 3 14
54. L. O'mahony, M. Feeney, S. O'halloran, L. Murphy, B. Kiely, J. Fitzgibbon, and et al. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice Aliment Pharmacol Ther 15 2001 1219 1225
55. H. Horie, M. Zeisig, K. Hirayama, T. Midtvedt, L. Möller, and J. Rafter Probiotic mixture decreases DNA adduct formation in colonic epithelium induced by the food mutagen 2-amino-9H-pyrido[2,3-b]indole in a human-flora associated mouse model Eur J Cancer Prev 12 2003 101 107
56. R.K. Le Leu, I.L. Brown, Y. Hu, A.R. Bird, M. Jackson, A. Esterman, and et al. A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon J Nutr 135 2005 996 1001
57. I. Bertkova, E. Hijova, A. Chmelarova, G. Mojzisova, D. Petrasova, L. Strojny, and et al. The effect of probiotic microorganisms and bioactive compounds on chemically induced carcinogenesis in rats Neoplasma 57 2010 422 428
58. R.K. Le Leu, Y. Hu, I.L. Brown, R.J. Woodman, and G.P. Young Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats Carcinogenesis 31 2010 246 251
59. V. Gosai, P. Ambalam, M. Raman, C.R. Kothari, R.K. Kothari, B.R.M. Vyas, and et al. Protective effect of Lactobacillus rhamnosus 231 against N-methyl-N'-nitro-N-nitrosoguanidine in animal model Gut Microbes 2 2011 1 7
60. N.P. Foo, H. Ou Yang, H.H. Chiu, H.Y. Chan, C.C. Liao, C.K. Yu, and et al. Probiotics prevent the development of 1,2-dimethylhydrazine (DMH)-induced colonic tumorigenesis through suppressed colonic mucosa cellular proliferation and increased stimulation of macrophages J Agric Food Chem 59 2011 13337 13345
61. J.H. Chang, Y.Y. Shim, S.K. Cha, and M.J. Reaney Chee KM. Effect of Lactobacillus acidophilus KFRI342 on the development of chemically induced precancerous growths in the rat colon J Med Microbiol 61 2012 361 368
62. A. Verma, and G. Shukla Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMH-induced procarcinogenicfecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in Sprague Dawley rats Nutr Cancer 65 2013 84 91
63. J. Zhu, C. Zhu, S. Ge, M. Zhang, L. Jiang, J. Cui, and et al. Lactobacillus salivarius Ren prevent the early colorectal carcinogenesis in 1, 2-dimethylhydrazine-induced rat model J Appl Microbiol 117 2014 208 216
64. S. Walia, R. Kamal, S.S. Kanwar, and D.K. Dhawan Cyclooxygenase as a target in chemoprevention by probiotics during 1,2-dimethylhydrazine induced colon carcinogenesis in rats Nutr Cancer 67 2015 603 611
65. Z.F. Chen, L.Y. Ai, J.L. Wang, L.L. Ren, Y.N. Yu, J. Xu, and et al. Probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis Future Microbiol 10 2015 1433 1445
66. S. Miquel, R. Martín, C. Bridonneau, V. Robert, H. Sokol, L.G. Bermúdez-Humarán, and et al. Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii Gut Microbes 5 2014 146 151
67. E. Quévrain, M.A. Maubert, C. Michon, F. Chain, R. Marquant, J. Tailhades, and et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease Gut 65 2016 415 425
68. C.C. Roy, C.L. Kien, L. Bouthillier, and E. Levy Short-chain fatty acids: ready for prime time? Nutr Clin Pract 21 2006 351 366
69. R.B. Canani, M.D. Costanzo, L. Leone, M. Pedata, R. Meli, and A. Calignano Potential beneficial effects of butyrate in intestinal and extraintestinal diseases World J Gastroenterol 17 2011 1519 1528
70. R.B. Canani, M. Di Costanzo, and L. Leone The epigenetic effects of butyrate: potential therapeutic implications for clinical practice Clin Epigenetics 4 2012 4
71. D. Scharlau, A. Borowicki, N. Habermann, T. Hofmann, S. Klenow, C. Miene, and et al. Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre Mutat Res 682 2009 39 53
72. M. Cho, J. Carter, S. Harari, and Z. Pei The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis Clin Lab Med 34 2014 699 710
73. C. Jobin Colorectal cancer: CRC-all about microbial products and barrier function? Nat Rev Gastroenterol Hepatol 9 2012 694 696
74. J.M. Uronis, M. Mühlbauer, H.H. Herfarth, T.C. Rubinas, G.S. Jones, and C. Jobin Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility PLoS One 4 2009 e6026
75. L. Vannucci, R. Stepankova, H. Kozakova, A. Fiserova, P. Rossmann, and H. Tlaskalova-Hogenova Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity Int J Oncol 32 2008 609 617
76. J. Barroso-Batista, J. Demengeot, and I. Gordo Adaptive immunity increases the pace and predictability of evolutionary change in commensal gut bacteria Nat Commun 6 2015 8945
77. I. Kahouli, C. Tomaro-Duchesneau, and S. Prakash Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives J Med Microbiol 62 2013 1107 1123
78. E.S. Chong A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action World J Microbiol Biotechnol 30 2014 351 374
79. A. Sivan, L. Corrales, N. Hubert, J.B. Williams, K. Aquino-Michaels, Z.M. Earley, and et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy Science 350 2015 1084 1089
80. K. Takeda, T. Suzuki, S.I. Shimada, K. Shida, M. Nanno, and K. Okumura Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota Clin Exp Immunol 146 2006 109 115
81. B. Foligne, G. Zoumpopoulou, J. Dewulf, A.B. Younes, F. Chareyre, J.C. Sirard, and et al. A key role of dendritic cells in probiotic functionality PLoS One 2 2007 e313
82. H.J. Kang, and S.H. Im Probiotics as an immune modulator J Nutr Sci Vitaminol (Tokyo) 61 2015 S103 S105
83. P. Forsythe, and J. Bienenstock Immunomodulation by commensal and probiotic bacteria Immunol Invest 39 2010 429 448
84. H.H. Smits, A. Engering, D. van der Kleij, E.C. de Jong, K. Schipper, T.M. van Capel, and et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in-vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin J Allergy Clin Immunol 115 2005 1260 1267
85. L.N. Fink, L.H. Zeuthen, H.R. Christensen, B. Morandi, H. Frøkiaer, and G. Ferlazzo Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses Int Immunol 19 2007 1319 1327
86. U. Daniluk Probiotics, the new approach for cancer prevention and/or potentialization of anti-cancer treatment? J Clin Exp Oncol 1 2012 2
87. M. Uccello, G. Malaguarnera, F. Basile, V. D'agata, M. Malaguarnera, G. Bertino, and et al. Potential role of probiotics on colorectal cancer prevention BMC Surg 12 2012 S35
88. M. Raman, P. Ambalam, and M. Doble Probiotics and colorectal cancer in probiotics and bioactive carbohydrates in colon cancer management Ist ed. 2016 Springer India 15 34
89. H.M. Becker, A. Apladas, M. Scharl, M. Fried, and G. Rogler Probiotic Escherichia coli Nissle 1917 and commensal E. coli K12 differentially affect the inflammasome in intestinal epithelial cells Digestion 89 2014 110 118
90. S. Song, S. Oh, and K.T. Lim The proteins (12 and 15 kDa) isolated from heat-killed Lactobacillus plantarum L67 induces apoptosis in HT-29 cells Cell Biochem Funct 33 2015 89 96
91. F. Yan, L. Liu, P.J. Dempsey, Y.H. Tsai, E.W. Raines, C.L. Wilson, and et al. A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor J Biol Chem 288 2013 30742 30751
92. L. Wang, H. Cao, L. Liu, B. Wang, W.A. Walker, S.A. Acra, and et al. Activation of epidermal growth factor receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GG-derived protein J Biol Chem 289 2014 20234 20244
93. K. Yoda, K. Miyazawa, M. Hosoda, M. Hiramatsu, F. Yan, and F. He Lactobacillus GG-fermented milk prevents DSS-induced colitis and regulates intestinal epithelial homeostasis through activation of epidermal growth factor receptor Eur J Nutr 53 2014 105 115
94. E.L. Ma, Y.J. Choi, J. Choi, C. Pothoulakis, S.H. Rhee, and E. Im The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition Int J Cancer 127 2010 780 790
95. X. Chen, J. Fruehauf, J.D. Goldsmith, H. Xu, K.K. Katchar, H. Koon, and et al. Saccharomyces boulardii inhibits EGF receptor signalling and intestinal tumour growth in Apc(min) mice Gastroenterology 137 2009 914 923
96. C. Pothoulakis Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii Aliment Pharmacol Ther 30 2009 826 833
97. J.P. Buts, and N. De Keyser Interaction of Saccharomyces boulardii with intestinal brush border membranes: key to probiotic effects? J Pediatr Gastroenterol Nutr 51 2010 532 533
98. G.R. Gibson, H.M. Probert, J. Van Loo, R.A. Rastall, and M.B. Roberfroid Dietary modulation of the human colonic microbiota: updating the concept of prebiotics Nutr Res Rev 17 2004 259 275
99. J.M. Bruno-Barcena, and M.A. Azcarate-Peril Galacto-oligosaccharides and colorectal cancer: feeding our intestinal probiome J Funct Foods 12 2015 92 108
100. A.A. Aachary, and S.G. Prapulla Xylooligosaccharides (XOS) as an emerging prebiotic: microbial synthesis, utilization, structural characterization, bioactive properties, and applications Comp Rev Food Sci Food Saf 10 2011 2 16
101. D.F. Birt, T. Boylston, S. Hendrich, J.L. Jane, J. Hollis, L. Li, and et al. Resistant starch: promise for improving human health Adv Nutr 4 2013 587 601
102. M.V. Wijnands, H.C. Schoterman, J.B. Bruijntjes, V.M. Hollanders, and R.A. Woutersen Effect of dietary galacto-oligosaccharides on azoxymethane-induced aberrant crypt foci and colorectal cancer in Fischer 344 rats Carcinogenesis 22 2001 127 132
103. C.K. Hsu, J.W. Liao, Y.C. Chung, C.P. Hsieh, and Y.C. Chan Xylooligosaccharides and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats J Nutr 134 2004 1523 1528
104. M. Bauer-Marinovic, S. Florian, K. Müller-Schmehl, H. Glatt, and G. Jacobasch Dietary resistant starch type 3 prevents tumor induction by 1, 2-dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon Carcinogenesis 27 2006 1849 1859
105. V.P. Gourineni, M. Verghese, J. Boateng, L. Shackelford, N.K. Bhat, and L.T. Walker Combinational effects of prebiotics and soybean against azoxymethane-induced colon cancer in-vivo J Nutri Metabol 2011 2011 868197
106. E. Hijova, V. Szabadosova, L. Strojny, and A. Bomba Changes chemopreventive markers in colorectal cancer development after inulin supplementation Bratisl Lek Listy 115 2014 76 79
107. H. Ishikawa, I. Akedo, T. Otani, T. Suzuki, T. Nakamura, I. Takeyama, and et al. Randomized trial of dietary fibre and Lactobacillus casei administration for prevention of colorectal tumours Int J Cancer 116 2005 762 767
108. Y. Aso, H. Akaza, T. Kotake, T. Tsukamoto, K. Imai, and S. Naito Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double blind trial Eur Urol 27 1995 104 109
109. K. Hatakka, R. Holma, H. El-Nezami, T. Suomalainen, M. Kuisma, M. Saxelin, and et al. The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon Int J Food Microbiol 128 2008 406 410
110. S. Kolida, and G.R. Gibson Synbiotics in health and disease Annu Rev Food Sci Technol 2 2011 373 393
111. M. Roller, Y. Clune, K. Collins, G. Rechkemmer, and B. Watzl Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients Br J Nutr 97 2007 676 684
112. J. Rafter, M. Bennett, G. Caderni, Y. Clune, R. Hughes, P.C. Karlsson, and et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients Am J Clin Nutr 85 2007 488 496
113. D.L. Worthley, R.K. Le Leu, V.L. Whitehall, M. Conlon, C. Christophersen, D. Belobrajdic, and et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer Am J Clin Nutr 90 2009 578 586
114. E. Montassier, T. Gastinne, P. Vangay, G.A. Al-Ghalith, S. Bruley des Varannes, S. Massart, and et al. Chemotherapy-driven dysbiosis in the intestinal microbiome Aliment Pharmacol Ther 42 2015 515 528
115. M. Wada, S. Nagata, M. Saito, T. Shimizu, Y. Yamashiro, T. Matsuki, and et al. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies Support Care Cancer 18 2010 751 759
116. B. Jeppsson, P. Mangell, and H. Thorlacius Use of probiotics as prophylaxis for postoperative infections Nutrients 3 2011 604 612
117. L. Gianotti, L. Morelli, F. Galbiati, R. Simona, C. Sara, B. Aldo, and et al. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients World J Gastroenterol 16 2010 167 175
118. Z.H. Liu, M.J. Huang, X.W. Zhang, L. Wang, N.Q. Huang, H. Peng, and et al. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-centre and double-blind randomized clinical trial Am J Clin Nutr 97 2013 117 126
119. Z. Liu, C. Li, M. Huang, C. Tong, X. Zhang, L. Wang, and et al. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial BMC Gastroenterol 15 2015 34
120. J.W. Zhang, P. Du, J. Gao, B.R. Yang, W.J. Fang, and C.M. Ying Preoperative probiotics decrease postoperative infectious complications of colorectal cancer Am J Med Sci 343 2012 199 205
121. G. Sugawara, M. Nagino, H. Nishio, T. Ebata, K. Takagi, T. Asahara, and et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial Ann Surg 244 2006 706 714